Facense Ltd develops lightweight smartglasses with tiny sensors that continuously and unobtrusively measure physiological signals and emotional responses. Facense smartglasses will detect heart rate, oxygen saturation, breathing rate, blood pressure, coughing and sneezing. Future software updates will support detection and prediction of various medical conditions, including hypertension, stroke, congestive heart failure, asthma, chronic obstructive pulmonary disease, and migraine. Facense's patent portfolio includes 40+ US patents and dozens of patent applications around the world on smartglasses with sensors for wellness, telehealth, safety, and industrial applications.
